⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SUPN News
Supernus Pharmaceuticals, Inc.
Form 8-K
sec.gov
SUPN
Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026
globenewswire.com
SUPN
Form 8-K
sec.gov
ACOG
BIIB
SUPN
KALV
From Automation to Autonomy: SUPCON to showcase next-generation technologies empowering Autonomous Operating Plants at Hannover Messe 2026 USA - English APAC - English USA - English
prnewswire.com
SUPN
Form 8-K
sec.gov
SUPN
Drug-Resistant Epilepsy Market to Accelerate With Significant CAGR by 2036 as Demand for Advanced Therapies Increases | DelveInsight
prnewswire.com
LIVN
PTC
UCB
XENE
AQST
TAK
BHVN
KNOP
VRTX
SUPN
GSK
SNY
MD
Form 8-K
sec.gov
SUPN
Form 8-K
sec.gov
SUPN
Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
SUPN
Supernus Pharmaceuticals to Participate in March Investor Conferences
globenewswire.com
SUPN